Nanomedicines for dysfunctional macrophage-associated diseases.

about

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis.Development of mannose functionalized dendrimeric nanoparticles for targeted delivery to macrophages: use of this platform to modulate atherosclerosis.Multivalent nanosystems: targeting monocytes/macrophages

P2860

Q33734806-36DDDF2D-7A97-4A47-8E9D-73D74B0B4158 Q45073834-EF72F8E8-D1D8-4B5B-AAF3-CB8A632D0C42 Q57073314-984F1A84-B974-4F60-ADB0-FBFC656CDABD

P2860

Nanomedicines for dysfunctional macrophage-associated diseases.

Item

http://www.wikidata.org/entity/Q39069052

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Nanomedicines for dysfunctional macrophage-associated diseases.

@en

Nanomedicines for dysfunctional macrophage-associated diseases.

@nl

type

Item

label

Nanomedicines for dysfunctional macrophage-associated diseases.

@en

Nanomedicines for dysfunctional macrophage-associated diseases.

@nl

prefLabel

Nanomedicines for dysfunctional macrophage-associated diseases.

@en

Nanomedicines for dysfunctional macrophage-associated diseases.

@nl

P1476

Nanomedicines for dysfunctional macrophage-associated diseases.

@en

P2093

Shobha Ghosh

http://www.w3.org/2001/XMLSchema#string

P2860

Imaging Atherosclerosis.

The Macrophage Switch in Obesity Development

The macrophage: a therapeutic target in HIV-1 infection

Anti-HIV-1 nanotherapeutics: promises and challenges for the future

Anti-inflammatory therapy in chronic disease: challenges and opportunities

Cholesterol efflux pathways regulate myelopoiesis: a potential link to altered macrophage function in atherosclerosis

Quantum dots as a platform for nanoparticle drug delivery vehicle design

The interaction of anticancer therapies with tumor-associated macrophages

High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis

The big picture on nanomedicine: the state of investigational and approved nanomedicine products

P304

106-126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JCONREL.2016.12.032

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

247

http://www.w3.org/2001/XMLSchema#string

P50

Hongliang He

Hu Yang

P577

2017-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28057522

http://www.w3.org/2001/XMLSchema#string

P921

macrophage

P932

5360184

http://www.w3.org/2001/XMLSchema#string

Nanomedicines for dysfunctional macrophage-associated diseases.

about

P2860

P2860

Nanomedicines for dysfunctional macrophage-associated diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932